Industry Calls For Changes To Maximize Benefits Of Off-Patent Oncology Drugs

Medicines For Europe Calls for ‘Highest Quality Patent System In Europe’

 
• By Akriti Seth
  
oncology
Medicines for Europe makes recommendations for better use of generics, biosimilars and value-added medicines in cancer care • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin